BOM

Photon IP is a deeptech startup located in Eindhoven, the Netherlands, specializing in the development of advanced technologies for photonics applications. The company focuses on creating application-specific semiconductors that cater to various industries, including automotive and telecommunications. Its innovative products are designed to enhance the production of wearable electronics and improve data center operations, providing tailored solutions that address the evolving needs of its clients.

Morphotonics specializes in the development and sale of nano- and micro-imprint structures, providing solutions for imprinting micro- and nanostructures onto both large rigid and flexible surfaces. The company manufactures nanoimprint lithography machines designed to facilitate the fabrication of advanced materials and devices. Their offerings include roll-to-plate nanoimprinting production lines, discrete flexible stamps for continuous processing, and the capability to pattern large substrates through sequential imprinting of small areas. This technology enables scalable manufacturing of micro- and nanostructured products, catering to various industries seeking innovative solutions in material fabrication.

SCIL Nanoimprint Solutions specializes in lithography technology designed for the patterning of nanostructures on large wafers. The company has developed a unique approach that merges the precision of rigid stamping with the adaptability of soft stamping techniques, effectively overcoming the limitations commonly associated with traditional rigid lithography. This innovative technology achieves nanometer resolution, making it suitable for applications in optics and various photonic products. By providing optimized equipment, consumable materials, and processes, SCIL Nanoimprint Solutions enables customers to enhance production efficiency, reduce end-product costs, and improve functionality, thereby supporting high-volume manufacturing in the nanotechnology sector.

VIVOLTA specializes in the contract development and manufacturing of electrospun medical products, focusing on nanofiber-based solutions that aid the body's natural healing processes. The company has developed advanced electrospinning technologies that replicate the human extracellular matrix in a scalable and reproducible manner. This includes a range of methods such as melt electrospinning, wet electrospinning, and emulsion electrospinning. VIVOLTA’s innovations provide medical professionals with effective tools to enhance the production of medical implants and support a variety of medical applications, thereby improving the efficiency of electrospinning research.

Cristal Therapeutics BV, established in 2011 and headquartered in Maastricht, the Netherlands, operates as a clinical-stage pharmaceutical company specializing in nanomedicine development. The company's core business revolves around its proprietary CriPec platform, which transforms drugs into nanoparticles for targeted delivery. Cristal Therapeutics focuses on treating diseases such as cancer by improving drug efficacy and safety profiles through this innovative technology.

VIVOLTA specializes in the contract development and manufacturing of electrospun medical products, focusing on nanofiber-based solutions that aid the body's natural healing processes. The company has developed advanced electrospinning technologies that replicate the human extracellular matrix in a scalable and reproducible manner. This includes a range of methods such as melt electrospinning, wet electrospinning, and emulsion electrospinning. VIVOLTA’s innovations provide medical professionals with effective tools to enhance the production of medical implants and support a variety of medical applications, thereby improving the efficiency of electrospinning research.